March 14, 2025
Willkie is advising PAI Partners on the sale of a majority stake in Amplitude Surgical to Zydus Lifesciences Limited at a price of €6.25 per Amplitude Surgical share.
On March 11, it was announced that Zydus entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical, France from PAI Partners and Amplitude Surgical’s management, as well as two minority shareholders, at a price of €6.25 per Amplitude Surgical share. Purchase consideration amounts to €256.8mn for 85.6% of the outstanding shares and voting rights of Amplitude Surgical, as of March 10, 2025.
Amplitude Surgical is a European MedTeach leader in high-quality, lower-limb orthopaedic technologies, providing numerous value-added innovations to best meet the needs of patients, surgeons and healthcare facilities. This includes the design and development of knee and hip prostheses, which are implanted in place of damaged or worn-out joints.
Supported by PAI Partners through its Mid-Market Fund, Amplitude Surgical has experienced significant growth over the last four years, driven by new product development, international growth, investments in manufacturing capabilities and R&D.
The Willkie team was led by partners Eduardo Fernandez and Gabriel Flandin, and included associates Mathilde Faure, Axel Rogeon and Floriane Teillet.
On March 11, it was announced that Zydus entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical, France from PAI Partners and Amplitude Surgical’s management, as well as two minority shareholders, at a price of €6.25 per Amplitude Surgical share. Purchase consideration amounts to €256.8mn for 85.6% of the outstanding shares and voting rights of Amplitude Surgical, as of March 10, 2025.
Amplitude Surgical is a European MedTeach leader in high-quality, lower-limb orthopaedic technologies, providing numerous value-added innovations to best meet the needs of patients, surgeons and healthcare facilities. This includes the design and development of knee and hip prostheses, which are implanted in place of damaged or worn-out joints.
Supported by PAI Partners through its Mid-Market Fund, Amplitude Surgical has experienced significant growth over the last four years, driven by new product development, international growth, investments in manufacturing capabilities and R&D.
The Willkie team was led by partners Eduardo Fernandez and Gabriel Flandin, and included associates Mathilde Faure, Axel Rogeon and Floriane Teillet.
